SynopsisThe global market for Orthopedic Bioabsorbable Fixation Devices was valued at US$ 557 million in the year 2024 and is projected to reach a revised size of US$ 826 million by 2031, growing at a CAGR of 5.7% during the forecast period. Orthopedic bioabsorb.....
SynopsisThe global market for Oncology Drugs was valued at US$ 239850 million in the year 2024 and is projected to reach a revised size of US$ 471950 million by 2031, growing at a CAGR of 10.3% during the forecast period. Cancer is the name given to a group of r.....
SynopsisThe global market for Blood Banking and Blood Products was valued at US$ 57320 million in the year 2024 and is projected to reach a revised size of US$ 91740 million by 2031, growing at a CAGR of 7.0% during the forecast period. Blood banking is the proc.....
SynopsisThe global market for Bioresorbable Scaffolds was valued at US$ 399 million in the year 2024 and is projected to reach a revised size of US$ 1321 million by 2031, growing at a CAGR of 18.9% during the forecast period. Bioabsorbable scaffolds, or naturall.....
SynopsisThe global market for Cryosurgery Units was valued at US$ 47.3 million in the year 2024 and is projected to reach a revised size of US$ 65.8 million by 2031, growing at a CAGR of 4.9% during the forecast period. Cryosurgery units are surgical instruments.....
SynopsisThe global market for Wearable Glucose Monitoring Device was valued at US$ 4260 million in the year 2024 and is projected to reach a revised size of US$ 6075 million by 2031, growing at a CAGR of 5.2% during the forecast period. A wearable glucose monito.....
SynopsisThe global market for Medical Specialty Enzymes was valued at US$ 924 million in the year 2024 and is projected to reach a revised size of US$ 1328 million by 2031, growing at a CAGR of 5.4% during the forecast period. Medical Specialty Enzymes contains .....
SynopsisThe global market for Orthokeratology was valued at US$ 1827 million in the year 2024 and is projected to reach a revised size of US$ 5533 million by 2031, growing at a CAGR of 17.4% during the forecast period. Ortho-K is a non-surgical refractive treatm.....
SynopsisThe global market for Oncaspar was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 281 million by 2031, growing at a CAGR of 11.4% during the forecast period. Oncaspar is a cancer medicine used in adults and chi.....
SynopsisThe global market for 3D Reconstructed Human Epidermis (RHE) Model was valued at US$ 29.2 million in the year 2024 and is projected to reach a revised size of US$ 70.1 million by 2031, growing at a CAGR of 13.9% during the forecast period. 3D Reconstruct.....
